Novabay pharmaceuticals and sonoma pharmaceuticals agree to market avenova-branded products in the european union through sonoma's extensive distributor network

Emeryville, calif. & boulder, colo.--(business wire)--novabay pharmaceuticals, inc. (nyse american: nby) and sonoma pharmaceuticals, inc. (nasdaq: snoa) today announced an agreement for the sale and marketing of avenova®-branded products by sonoma in the european union. the new products will combine sonoma's existing eye product ocudox®, which has already received a class iib ce mark for sale in the european union, with avenova branding, and are expected to be marketed through sonoma's establis.
SNOA Ratings Summary
SNOA Quant Ranking